Our findings also confirmed the view that ALK rearrangements are more common in patients at advanced NSCLC [69], [72] and in patients with lung adenocarcinoma than with non-adenocarcinoma especially squamous cell carcinoma [8], [9]. This evidence concerns the gene ALK and non-small cell lung carcinoma.